The Adeno-Associated Virus Gene Therapy Market was valued at approximately ~USD 2000 Million in 2023 and is expected to grow at a strong CAGR of around 39% during the forecast period (2024-2032)
Adeno-Associated Virus (AAV) gene therapy has emerged as a groundbreaking approach in the treatment of various genetic and acquired disorders. In the United States, the field has seen remarkable...
About
Voorwaarden
Privacy
Contact
Invest
Thai
English
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian